LUPTAKOVA KATARINA (Chief Medical Officer) exercised options at XILIO THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001193125-26-002520
Officer· Chief Medical Officer
Since Sep 2023
+451.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
468.51K acquired · 16.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.63K
Price / share
—
Trade value
—
% of position
100.0%
1/1/2026
16.63K→33.25K
Total
Net shares
+16.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +16.63K | — | — | 100.0% | 16.63K | 33.25K |
| Total | +16.63K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
451.88K shares
Shares
+451.88K
Strike price
0.841
Held after
451.88K
Exercisable
—
12/31/2025
Restricted Stock Units
Direct
Converts to
Common Stock
16.63K shares
Shares
−16.63K
Strike price
Held after
33.25K
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock451.88K shares | 12/31/2025 | A · Award | +451.88K | 0.841 | — | 451.88K |
| Restricted Stock Units Direct | Common Stock16.63K shares | 1/1/2026 | M · Option Exercise | −16.63K | — | 33.25K |